Belgium’s BioFirst Group has agreed to buy the remaining 50% of Biobest Maroc for €30 million, a proposed ownership consolidation at a major Moroccan production site for beneficial insects used in biological crop protection. BioFirst’s parent, Floridienne, disclosed the value in an 11 September 2026 regulatory press release.
The planned transaction would increase Biobest’s shareholding from 50% to 100%. However, completion still depends on approval from Morocco’s Competition Council; an announced agreement and a regulatory notification are not the same as a completed acquisition.
What is being acquired?
Biobest Maroc S.A.R.L. operates in the Chtouka-Aït Baha area near Agadir, one of Morocco’s important horticultural production regions. The site produces beneficial insects that growers use to control crop pests as part of integrated pest management. BioFirst says the production subsidiary supplies customers across the group’s international markets.
A 10 September Competition Council notification confirms the proposal concerns the other half of Biobest Maroc’s shares and voting rights. The regulator explicitly cautions that publication of a notified transaction does not establish its approval. The proposed acquisition is an equity ownership change, not a newly announced greenhouse construction project.
€30 million price confirmed in parent-company filing
Floridienne’s 30 September half-year report provides a further detail absent from the shorter Biobest statement: it dates the purchase agreement to 15 July 2026, before September’s public announcements. The group says the €30 million consideration is to be financed with equity and a loan.
Floridienne states that Biobest Maroc was already controlled and fully consolidated before the transaction. Buying out the minority partner therefore changes the allocation of earnings attributable to owners rather than immediately adding new revenue to consolidated group turnover. The company expects regulatory clearance before the end of 2026 but does not provide a completed closing date.
The existing Moroccan commercial entity will continue operating unchanged, according to BioFirst’s September announcement. The stated strategy is to strengthen control of biological production and supply relationships; no new output volumes or employment changes have been verified.
Key takeaways
- BioFirst agreed to acquire the other 50% of Biobest Maroc in a €30 million transaction; Floridienne dates the signing to 15 July.
- The Moroccan regulator has received a filing, but the inspected primary releases do not confirm approval or legal closing.
- The site produces biological-control organisms. The reported ownership transaction does not document new production capacity.
Featured image: Biobest Maroc’s production facility, from BioFirst Group’s September announcement.
